C

ChromaDex Corp
D

CDXC

2.74000
USD
-0.24
(-8.05%)
Market Closed
Volume
48,688
EPS
0
Div Yield
0
P/E
-205
Market Cap
464,331,133
OverviewSignalsIdeasNews
Related Instruments
    A
    ACIU
    -0.24000
    (-5.91%)
    3.82000 USD
    K
    KALA
    -0.29000
    (-4.40%)
    6.30000 USD
    P
    PRQR
    -0.10000
    (-5.24%)
    1.81000 USD
    P
    PSTX
    -0.22500
    (-6.36%)
    3.31500 USD
    R
    RGNX
    -0.920
    (-6.44%)
    13.370 USD
News

Title: ChromaDex Corp

Sector: Consumer Defensive
Industry: Packaged Foods
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.